Exploring Ongoing Clinical Trials On Using Ctdna Results To Guide Gi Cancer Management
If you are looking for information about Ongoing Clinical Trials On Using Ctdna Results To Guide Gi Cancer Management, you have come to the right place.
- Dr John Stricker reviews the “Circulate”
- Emerik Osterlund, MD, PhD, The University of Texas MD Anderson
- Mitsuru Yokota, MD, PhD, Kurashiki Central Hospital, Kurashiki, Japan, discusses
- Dr Tie talks to ecancer at ASCO 2025 about data she presented from the AGITG DYNAMIC-III
- In recognition of
In-Depth Information on Ongoing Clinical Trials On Using Ctdna Results To Guide Gi Cancer Management
Suneel Kamath, MD, Cleveland Clinic, Cleveland, OH, outlines two key Gunnar Folprecht, MD, PhD, Technical University Dresden, Dresden, Germany, discusses background and Prof David Kerr discusses a paper illustrating the role of Professor Jeanne Tie of @petermaccancercentre discusses 5-year outcomes from the randomized DYNAMIC
In this episode of the Oncology Brothers podcast, cohosts Rahul Gosain, MD, MBA, of Wilmot
We hope this detailed breakdown of Ongoing Clinical Trials On Using Ctdna Results To Guide Gi Cancer Management was helpful.